Positive Attributes of Anti-TERT CD4 T-Helper Type 1 Immune Responses in Melanoma.
J Invest Dermatol
; 142(2): 279-281, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-34666894
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Telomerase
/
Melanoma
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
J Invest Dermatol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: